Novartis agrees to make ingredients Roche’s Actemra for COVID-19 patients
Swiss drugmaker Novartis has signed a deal to make ingredients for Roche's Actemra remedy that's being repurposed for individuals with COVID-19, the corporate…
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More